McGill University today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative research projects in the area of lipid nanoparticles (LNPs). LNPs are critical components in mRNA medicines such as vaccines, as they are the primary delivery method of mRNA strands to the target cells.
Category:
Published on: 19 Jul 2023
For most people, the influenza A virus (IAV), commonly known as the flu, is cleared from the body by our own immune system. In some cases, however, the immune response becomes dysregulated and if left uncontrolled, the inflammation caused by our own immune cells can lead to extensive lung tissue damage and enhanced morbidity and mortality.
How can we help our immune system to balance the two main host defense strategies: attacking pathogens (called host resistance) and preserving our own tissue (called disease tolerance)?
Category:
Published on: 22 May 2019
Scientists at McGill University have developed a new method to study how seizures arise in the healthy brain. Using laser light guided through ultra-thin optic fibers in the brain of rodents, the researchers “turned on” light-sensitive proteins in selective brain cells and were able to eventually cause seizures through repeated laser stimulation. These findings were published March 27, 2019 in the journal Scientific Reports.
Category:
Published on: 27 Mar 2019
In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Centre (MUHC) and McGill University have delivered encouraging news for chronic pain sufferers by pinpointing the effective dose of marijuana plant extract cannabidiol (CBD) for safe pain relief without the typical “high” or euphoria produced by the THC. The findings of their study have been published in the journal PAIN.
Category:
Published on: 25 Oct 2018
The Research Institute of the McGill University Health Centre’s (RI-MUHC) push to treat a rare genetic disease in children – with a higher percentage found in French Canadians – has received $2 million as part of a national genomic contest led by Genome Canada.
Category:
Published on: 4 Oct 2018
Preterm birth is a major global public health problem. Every year, 15 million babies are born prematurely and many will suffer from neurodegenerative disorders, including cerebral palsy, learning disabilities, impaired vision, and behavioural problems.
Category:
Published on: 4 Sep 2018
The funding will be split between separate projects looking into the properties of cannabidiol and a search for a new treatment of an aggressive brain cancer.
Category:
Published on: 16 Aug 2018
A team from the Research Institute of McGill University Health Centre (RI-MUHC) in Montreal has joined forces with researchers at Johns Hopkins to bring screening and early detection of ovarian and uterine cancers one step closer to clinical implementation. Researchers developed a test that provides a safe and minimally invasive method for earlier diagnosis of ovarian and endometrial cancers.
Category:
Published on: 21 Mar 2018
Rare hereditary recessive diseases were thought to be expressed in offspring only when both parents carry a mutation in the causal gene, but a new study is changing this paradigm. An international research team led by scientists at the University of Lorraine in France along with McGill University and the Research Institute of the McGill University Health Centre (RI-MUHC) in Canada discovered a new cause of a rare condition known as cblC, that they named “epi-cblC”. They reported it in patients from Europe and the United States.
Category:
Published on: 30 Jan 2018
Research has already shown that women who develop either diabetes or high blood pressure during pregnancy are at risk of getting type 2 diabetes, high blood pressure or heart disease years later. Now, a new study from a team at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University shows that the risk of developing those conditions post pregnancy is drastically higher if the women had both diabetes and high blood pressure during pregnancy. The study, published today in the American Journal of Epidemiology, doesn’t end with the mother’s risks.
Category:
Published on: 14 Nov 2017
By Julie Robert
Category:
Published on: 26 Sep 2017
A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor could improve the prognosis for patients and may help them avoid unnecessary and invasive treatments. Using a database of 580 women with triple negative breast cancer (TNBC), the researchers found that survival was prolonged in patients who expressed the prolactin receptor and that prolactin hormone was able to reduce the aggressive behavior of cancerous cells. It does so by decreasing their ability to divide and form new tumors.
Category:
Published on: 25 Oct 2016
By Julie Robert, McGill University Health Centre
Canadian researchers describe the first outbreak of Cryptosporidium parasite in Nunavik
Category:
Published on: 28 Apr 2016
Pages
